Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909492 · ClinicalTrials.gov registry record
Measurement of Relaxin Peptide in Multiple Sclerosis (MS)
A clinical trial, sponsored by Providence Health & Services.
- Completed
- Registry status
- 30
- Enrollment target
NCT01909492 is a clinical trial that has completed, run by Providence Health & Services. The registered enrollment target is 30 participants.
The verdict
NCT01909492 has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis.
Interventions
- PROCEDURE Lumbar Puncture
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-09-20 |
| Est. Completion | 2023-10-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01909492
The ClinicalTrials.gov registry entry for NCT01909492 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lumbar Puncture is the first listed.
NCT01909492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01909492 about?
NCT01909492 is a clinical study titled "Measurement of Relaxin Peptide in Multiple Sclerosis (MS)". This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis.
What is the current status of trial NCT01909492?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-09-20. Estimated completion is 2023-10-05.
What interventions are being tested in trial NCT01909492?
The interventions under investigation include: Lumbar Puncture (PROCEDURE), Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT01909492?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.